ReviewThe Lancet. Public health2022
Extending a lifeline to people with HIV and opioid use disorder during the war in Ukraine.
Abstract readReview
In one paragraph
Review in The Lancet. Public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine.Contemporary clinical trials · 2024Trial
- Effects of a social network intervention on HIV seroconversion among people who inject drugs in Ukraine: moderation by network gender composition.Harm reduction journal · 2023Trial
- Injection Drug Use and Sexual Risk Behaviors Among People who Inject Drugs in Ukraine: A Random-Intercept Latent Transition Analysis.AIDS and behavior · 2023Trial
- War-related displacement, conflict intensity, and treatment delivery factors in opioid agonist maintenance treatment discontinuation following Russia's invasion of Ukraine: a national cohort study.The Lancet regional health. Europe · 2026Article
- Exploring multi-level barriers and human-centered solutions to expand methadone for HIV prevention among people who inject drugs in Kyrgyzstan.Journal of substance use and addiction treatment · 2026Article
- Holding the line: Provider and patient perspectives on Medications for Opioid Use Disorder continuity during the war in Ukraine.PloS one · 2026Article
- Probation as a targeted entry point for scaling up opioid agonist therapies in Moldova using a modified screening, brief intervention and referral to treatment strategy.PLOS global public health · 2026Article
- Disruptions to HIV Prevention During Armed Conflict in Ukraine and Other Settings.Current HIV/AIDS reports · 2024Review
- Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020-2023.Harm reduction journal · 2024Article
- "Will you need this health at all? Will you be alive?": using the bioecological model of mass trauma to understand HIV care experiences during the war in Ukraine.Journal of the International AIDS Society · 2024Article
- The impact of the 2014 military conflict in the east of Ukraine and the Autonomous Republic of the Crimea among patients receiving opioid agonist therapies.Journal of substance use and addiction treatment · 2024Article
- Preferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey.PLOS global public health · 2024Article
- Qualitative study of barriers and facilitators to HIV detection and treatment among women who inject drugs during the war against Ukraine.AIDS research and therapy · 2023Article
- Global HIV control: is the glass half empty or half full?The lancet. HIV · 2023Review
- Design, implementation and preliminary results of a type-2 hybrid cluster-randomized trial of integrating screening and treatment for major depressive disorder into specialty clinics providing opioid agonist therapies in Ukraine.Contemporary clinical trials · 2023Article
- Treatment of opioid use disorder in Ukraine during the first year of the Russia-Ukraine war: Lessons learned from the crisis.The International journal on drug policy · 2023Review
- "Medications for opioid use disorder during the war in Ukraine: a more comprehensive view on the government response-Authors' reply".The Lancet regional health. Europe · 2023Article
- Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?Frontiers in public health · 2023Article
- Treatment System Adaptations during War: Lessons from Ukrainian Addiction Treatment Providers.Substance use & misuse · 2023Article
- Leveraging existing provider networks in Europe to eliminate barriers to accessing opioid agonist maintenance therapies for Ukrainian refugees.PLOS global public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Frederick L AlticeSection of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA; Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, USA; Yale Institute for Global Health, Yale University, New Haven, CT, USA; APT Foundation, New Haven, CT, USA. Electronic address: frederick.altice@yale.edu.
Daniel J BrombergSection of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, USA; Department of Social and Behavioral Sciences, Yale University, New Haven, CT, USA; Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, USA.
Sergii DvoriakUkrainian Institute on Public Health Policy, Kyiv, Ukraine.
Anna MeteliukAlliance for Public Health of Ukraine, Kyiv, Ukraine.
Iryna PykaloUkrainian Institute on Public Health Policy, Kyiv, Ukraine.
Zahedul IslamAlliance for Public Health of Ukraine, Kyiv, Ukraine.
Lyu AzbelDepartment of Social and Behavioral Sciences, Yale University, New Haven, CT, USA; Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, USA.
Lynn M MaddenSection of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, USA; APT Foundation, New Haven, CT, USA.
Funding
Expanding Medication Assisted Therapy in Ukraine (ExMAT)R01DA033679 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2012 to 2021
$6.4MIntegrating Addiction Treatment and HIV Services into Primary Care Clinics in UkraineR01DA043125 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2016 to 2021
$4.4MExpanding Medication Assisted Therapies in Central AsiaR01DA054851 · NIDA · YALE UNIVERSITY · PI FREDERICK LEWIS ALTICE, Lynn Madden · 2022 to 2026
$2.9MModeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central AsiaR21DA047902 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2020 to 2021
$378kDeveloping, Implementing, and Pilot Testing an Informed Decision Aid for Opioid Agonist Therapies for Prisoners in UkraineF31DA054861 · NIDA · YALE UNIVERSITY · PI BROMBERG, DANIEL J · 2021 to 2023
$94kNIDA NIH HHS F31 DA054861NIDA NIH HHS R01 DA033679NIDA NIH HHS R01 DA043125NIDA NIH HHS R01 DA054851NIDA NIH HHS R21 DA047902
Abstract
PubMed holds no abstract for this paper.
Indexed as
HIV InfectionsOpioid-Related DisordersSubstance Abuse, IntravenousHumansUkraine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.